United States Influenza Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 17-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%)

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%)

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Influenza Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Influenza Vaccine revenues share in United States market, 2020 (%)

Key companies Influenza Vaccine sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Influenza Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- Hulan Bio

- AstraZeneca

- CCBIO

United States Influenza Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Influenza Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Influenza Vaccine Overall Market Size
2.1 United States Influenza Vaccine Market Size: 2021 VS 2027
2.2 United States Influenza Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Influenza Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Influenza Vaccine Players in United States Market
3.2 Top United States Influenza Vaccine Companies Ranked by Revenue
3.3 United States Influenza Vaccine Revenue by Companies
3.4 United States Influenza Vaccine Sales by Companies
3.5 United States Influenza Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in United States Market
3.8.1 List of Tier 1 Influenza Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Influenza Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Influenza Vaccine Market Size Markets, 2021 & 2027
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - United States Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - United States Influenza Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Influenza Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Influenza Vaccine Sales & Forecasts
4.3.1 By Type - United States Influenza Vaccine Sales, 2016-2021
4.3.2 By Type - United States Influenza Vaccine Sales, 2022-2027
4.3.3 By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Influenza Vaccine Market Size, 2021 & 2027
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - United States Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - United States Influenza Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Influenza Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Influenza Vaccine Sales & Forecasts
5.3.1 By Application - United States Influenza Vaccine Sales, 2016-2021
5.3.2 By Application - United States Influenza Vaccine Sales, 2022-2027
5.3.3 By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Overview
6.1.3 CSL Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 CSL Influenza Vaccine Product Description
6.1.5 CSL Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK Influenza Vaccine Product Description
6.2.5 GSK Recent Developments
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Overview
6.3.3 Sanofi Pasteur Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Sanofi Pasteur Influenza Vaccine Product Description
6.3.5 Sanofi Pasteur Recent Developments
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Overview
6.4.3 Mylan Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Mylan Influenza Vaccine Product Description
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Overview
6.5.3 Hulan Bio Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Hulan Bio Influenza Vaccine Product Description
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Overview
6.6.3 AstraZeneca Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 AstraZeneca Influenza Vaccine Product Description
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Corporation Information
6.7.2 CCBIO Overview
6.7.3 CCBIO Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 CCBIO Influenza Vaccine Product Description
6.7.5 CCBIO Recent Developments
7 United States Influenza Vaccine Production Capacity, Analysis
7.1 United States Influenza Vaccine Production Capacity, 2016-2027
7.2 Influenza Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Influenza Vaccine Supply Chain Analysis
9.1 Influenza Vaccine Industry Value Chain
9.2 Influenza Vaccine Upstream Market
9.3 Influenza Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Influenza Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Influenza Vaccine in United States Market
Table 2. Top Influenza Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Influenza Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Influenza Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Influenza Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Influenza Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Influenza Vaccine Product Type
Table 9. List of Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Trivalent Influenza Vaccine
Table 12. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 13. By Type - United States Influenza Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 23. CSL Corporation Information
Table 24. CSL Description and Major Businesses
Table 25. CSL Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. CSL Influenza Vaccine Product
Table 27. CSL Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. GSK Influenza Vaccine Product
Table 32. GSK Recent Developments
Table 33. Sanofi Pasteur Corporation Information
Table 34. Sanofi Pasteur Description and Major Businesses
Table 35. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Sanofi Pasteur Influenza Vaccine Product
Table 37. Sanofi Pasteur Recent Developments
Table 38. Mylan Corporation Information
Table 39. Mylan Description and Major Businesses
Table 40. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Mylan Influenza Vaccine Product
Table 42. Mylan Recent Developments
Table 43. Hulan Bio Corporation Information
Table 44. Hulan Bio Description and Major Businesses
Table 45. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Hulan Bio Influenza Vaccine Product
Table 47. Hulan Bio Recent Developments
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Major Businesses
Table 50. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. AstraZeneca Influenza Vaccine Product
Table 52. AstraZeneca Recent Developments
Table 53. CCBIO Corporation Information
Table 54. CCBIO Description and Major Businesses
Table 55. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 56. CCBIO Influenza Vaccine Product
Table 57. CCBIO Recent Developments
Table 58. Influenza Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 59. United States Influenza Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Influenza Vaccine Market Opportunities & Trends in United States Market
Table 61. Influenza Vaccine Market Drivers in United States Market
Table 62. Influenza Vaccine Market Restraints in United States Market
Table 63. Influenza Vaccine Raw Materials
Table 64. Influenza Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical Influenza Vaccine Downstream
Table 66. Influenza Vaccine Downstream Clients in United States Market
Table 67. Influenza Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Influenza Vaccine Segment by Type
Figure 3. Influenza Vaccine Segment by Application
Figure 4. United States Influenza Vaccine Market Overview: 2020
Figure 5. United States Influenza Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Influenza Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Influenza Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 9. Trivalent Influenza Vaccine Product Picture
Figure 10. Quadrivalent Influenza Vaccine Product Picture
Figure 11. By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 14. For Children (6 months to 3 years)
Figure 15. For Adults and Children over 3 years
Figure 16. By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 17. By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 18. By Application - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 19. CSL Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. GSK Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi Pasteur Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mylan Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hulan Bio Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. AstraZeneca Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. CCBIO Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Influenza Vaccine Production Capacity (M Doses), 2016-2027
Figure 27. Influenza Vaccine Industry Value Chain
Figure 28. Marketing Channels
  • Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 19-Oct-2021        Price: US 3480 Onwards        Pages: 94
    The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest resea......
  • Global Avian Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 11-Oct-2021        Price: US 3480 Onwards        Pages: 119
    The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Encephalitis Vaccination Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 87
    The Encephalitis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 84
    The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. A......
  • Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
    Published: 06-Oct-2021        Price: US 3900 Onwards        Pages: 106
    Global Meningococcal Conjugate Scope and Market Size Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment......
  • Global and China H1N1 Vaccines Market Insights, Forecast to 2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 142
    H1N1 Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the H1N1 Vaccines market size by ......
  • Global and China Encephalitis Vaccine Market Insights, Forecast to 2027
    Published: 21-Sep-2021        Price: US 3900 Onwards        Pages: 142
    Encephalitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Encephalitis Va......
  • United States Influenza Vaccine Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%) - Trivalent Influenza Vaccine - Quadrivalent Influenza Vaccine United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%) - For Children (6 months to......
  • 2021-2027 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 13-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 1986.07 Million USD in 2020 and will grow with a CAGR of 14.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(N......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs